3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Influenza, Human
10
Neoplasms
6
Neoplasms, Plasma Cell
2
Myelodysplastic Syndromes
2
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Leukemia, Myeloid, Acute
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia
2
Colorectal Neoplasms
2
Central Nervous System Neoplasms
2
Waldenstrom Macroglobulinemia
1
Virus Diseases
1
Vaccine-Preventable Diseases
1
Vaccination Hesitancy
1
Sezary Syndrome
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Patient Acceptance of Health Care
1
Oligodendroglioma
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Interventions
COVID-19 Vaccines
4
Blood Specimen Collection
4
Surveys and Questionnaires
3
Standard of Care
3
2019-nCoV Vaccine mRNA-1273
3
Pandemic Preparedness
2
sotrovimab
1
sinovac COVID-19 vaccine
1
selinexor
1
regorafenib
1
proxalutamide
1
monalizumab
1
lenzilumab
1
ciclesonide
1
bemcentinib
1
avdoralimab
1
acalabrutinib
1
XAV-19
1
Surgical Procedures, Operative
1
Sperm Count
1
Specimen Handling
1
Sorafenib
1
Sodium Chloride
1
Rabeprazole
1
Patient Reported Outcome Measures
1
Observation
1
Nutritional Status
1
Niclosamide
1
Meopa
1
Mastectomy, Segmental
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
COVID-19
×
Influenza Vaccines
×
Clear all
NCT06124131
2025-05-04
BENEFIT-C
Tulane University
Phase NA
Completed
50 enrolled
15 charts